| From dopamine to salience to psychosis—linking biology, pharmacology and phenomenology of psychosis S Kapur, R Mizrahi, M Li Schizophrenia research 79 (1), 59-68, 2005 | 558 | 2005 |
| Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes E Setiawan, AA Wilson, R Mizrahi, PM Rusjan, L Miler, G Rajkowska, ... JAMA psychiatry 72 (3), 268-275, 2015 | 527 | 2015 |
| A prospective longitudinal study of apathy in Alzheimer’s disease SE Starkstein, R Jorge, R Mizrahi, RG Robinson Journal of Neurology, Neurosurgery & Psychiatry 77 (1), 8-11, 2006 | 325 | 2006 |
| The construct of minor and major depression in Alzheimer’s disease SE Starkstein, R Jorge, R Mizrahi, RG Robinson American Journal of Psychiatry 162 (11), 2086-2093, 2005 | 285 | 2005 |
| Differential Effects of Aripiprazole on D 2 , 5-HT 2 , and 5-HT 1A Receptor Occupancy in Patients With Schizophrenia: A Triple … D Mamo, A Graff, R Mizrahi, CM Shammi, F Romeyer, S Kapur American Journal of Psychiatry 164 (9), 1411-1417, 2007 | 243 | 2007 |
| Increased stress-induced dopamine release in psychosis R Mizrahi, J Addington, PM Rusjan, I Suridjan, A Ng, I Boileau, ... Biological psychiatry 71 (6), 561-567, 2012 | 242 | 2012 |
| On the overlap between apathy and depression in dementia SE Starkstein, L Ingram, ML Garau, R Mizrahi Journal of Neurology, Neurosurgery & Psychiatry 76 (8), 1070-1074, 2005 | 240 | 2005 |
| Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review MO Trépanier, KE Hopperton, R Mizrahi, N Mechawar, RP Bazinet Molecular psychiatry 21 (8), 1009-1026, 2016 | 221 | 2016 |
| A diagnostic formulation for anosognosia in Alzheimer’s disease SE Starkstein, R Jorge, R Mizrahi, RG Robinson Journal of Neurology, Neurosurgery & Psychiatry 77 (6), 719-725, 2006 | 219 | 2006 |
| Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D 2 receptors: a PET study in schizophrenia R Mizrahi, P Rusjan, O Agid, A Graff, DC Mamo, RB Zipursky, S Kapur American Journal of Psychiatry 164 (4), 630-637, 2007 | 174 | 2007 |
| Binding characteristics and sensitivity to endogenous dopamine of [11C]‐(+)‐PHNO, a new agonist radiotracer for imaging the high‐affinity state of D2 receptors in vivo using … N Ginovart, L Galineau, M Willeit, R Mizrahi, PM Bloomfield, P Seeman, ... Journal of neurochemistry 97 (4), 1089-1103, 2006 | 153 | 2006 |
| Imaging Neuroinflammation in Gray and White Matter in Schizophrenia: An In-Vivo PET Study With [ 18 F]-FEPPA M Kenk, T Selvanathan, N Rao, I Suridjan, P Rusjan, G Remington, ... Schizophrenia bulletin 41 (1), 85-93, 2015 | 149 | 2015 |
| Depression in Alzheimer's disease: phenomenology, clinical correlates and treatment SE Starkstein, R Mizrahi, BD Power International Review of Psychiatry 20 (4), 382-388, 2008 | 135 | 2008 |
| Insight and danger in Alzheimer's disease SE Starkstein, R Jorge, R Mizrahi, J Adrian, RG Robinson European journal of neurology 14 (4), 455-460, 2007 | 131 | 2007 |
| ‘Jumping to conclusions’ and delusions in psychosis: relationship and response to treatment M Menon, R Mizrahi, S Kapur Schizophrenia research 98 (1-3), 225-231, 2008 | 125 | 2008 |
| How antipsychotics work—from receptors to reality S Kapur, O Agid, R Mizrahi, M Li NeuroRx 3 (1), 10-21, 2006 | 125 | 2006 |
| Neuroimaging correlates of apathy and depression in Alzheimer’s disease SE Starkstein, R Mizrahi, AA Capizzano, L Acion, S Brockman, BD Power The Journal of neuropsychiatry and clinical neurosciences 21 (3), 259-265, 2009 | 121 | 2009 |
| Translocator Protein (18 kDa) Polymorphism (rs6971) Explains in-vivo Brain Binding Affinity of the PET Radioligand [18F]-FEPPA R Mizrahi, PM Rusjan, J Kennedy, B Pollock, B Mulsant, I Suridjan, ... Journal of Cerebral Blood Flow & Metabolism 32 (6), 968-972, 2012 | 120 | 2012 |
| White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer’s disease AA Capizzano, L Acion, T Bekinschtein, M Furman, H Gomila, A Martinez, ... Journal of Neurology, Neurosurgery & Psychiatry 75 (6), 822-827, 2004 | 120 | 2004 |
| The dopamine D 2 receptors in high-affinity state and D 3 receptors in schizophrenia: a clinical [11 C]-(+)-PHNO PET study A Graff-Guerrero, R Mizrahi, O Agid, H Marcon, P Barsoum, P Rusjan, ... Neuropsychopharmacology 34 (4), 1078-1086, 2009 | 118 | 2009 |
